Article Versions Notes

Peltanova B, Liskova M, Gumulec J, Raudenska M, Polanska HH, Vaculovic T, Kalfert D, Grega M, Plzak J, Betka J, et al. Sensitivity to Cisplatin in Head and Neck Cancer Cells Is Significantly Affected by Patient-Derived Cancer-Associated Fibroblasts. International Journal of Molecular Sciences. 2021; 22(4):1912. https://doi.org/10.3390/ijms22041912

Peltanova, Barbora, Marketa Liskova, Jaromir Gumulec, Martina Raudenska, Hana Holcova Polanska, Tomas Vaculovic, David Kalfert, Marek Grega, Jan Plzak, Jan Betka, and et al. 2021. "Sensitivity to Cisplatin in Head and Neck Cancer Cells Is Significantly Affected by Patient-Derived Cancer-Associated Fibroblasts" International Journal of Molecular Sciences 22, no. 4: 1912. https://doi.org/10.3390/ijms22041912

Peltanova, B., Liskova, M., Gumulec, J., Raudenska, M., Polanska, H. H., Vaculovic, T., Kalfert, D., Grega, M., Plzak, J., Betka, J., & Masarik, M. (2021). Sensitivity to Cisplatin in Head and Neck Cancer Cells Is Significantly Affected by Patient-Derived Cancer-Associated Fibroblasts. International Journal of Molecular Sciences, 22(4), 1912. https://doi.org/10.3390/ijms22041912